INNOVA CAPTAB
Back to Balance Sheet
|
INNOVA CAPTAB Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹256 Cr | ₹205 Cr | ₹194 Cr | ₹88 Cr | ₹44 Cr |
What is the latest Total Non-Current Liabilities ratio of INNOVA CAPTAB ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹256 Cr |
| Mar2024 | ₹205 Cr |
| Mar2023 | ₹194 Cr |
| Mar2022 | ₹88 Cr |
| Mar2021 | ₹44 Cr |
How is Total Non-Current Liabilities of INNOVA CAPTAB Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹256 Cr | 25.03 | |
| Mar2024 | ₹205 Cr | 5.35 | |
| Mar2023 | ₹194 Cr | 120.40 | |
| Mar2022 | ₹88 Cr | 97.99 | |
| Mar2021 | ₹44 Cr | - | |
Compare Total Non-Current Liabilities of peers of INNOVA CAPTAB
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INNOVA CAPTAB | ₹4,136.7 Cr | 2.4% | 1.2% | -34% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹414,929.0 Cr | 0.7% | -4.2% | -8.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹169,644.0 Cr | 0% | -1% | 4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹131,481.0 Cr | 2.4% | 4.5% | 14.5% | Stock Analytics | |
| CIPLA | ₹122,050.0 Cr | 1.1% | 0.2% | -1.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹104,784.0 Cr | -1% | -2% | -9.7% | Stock Analytics | |
INNOVA CAPTAB Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INNOVA CAPTAB | 2.4% |
1.2% |
-34% |
| SENSEX | 0.9% |
0.7% |
9.6% |
You may also like the below Video Courses